Follow
Mario Valenti
Mario Valenti
Verified email at humanitas.it
Title
Cited by
Cited by
Year
Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital
M Valenti, G Pavia, L Gargiulo, P Facheris, O Nucca, L Mancini, F Sacrini, ...
International journal of dermatology 60 (7), 860-863, 2021
412021
Brodalumab: a new way to inhibit IL‐17 in psoriasis
P Facheris, M Valenti, G Pavia, E Guanziroli, A Narcisi, RG Borroni, ...
Dermatologic Therapy 33 (3), e13403, 2020
282020
Real-life effectiveness and safety of risankizumab in 131 patients affected by moderate-to-severe plaque psoriasis: a 52-week retrospective study
L Gargiulo, L Ibba, G Pavia, CA Vignoli, F Piscazzi, M Valenti, F Sanna, ...
Dermatology and Therapy 12 (10), 2309-2324, 2022
262022
Real-life effectiveness and safety of risankizumab in moderate-to-severe plaque psoriasis: a 40-week multicentric retrospective study
RG Borroni, P Malagoli, L Gargiulo, M Valenti, G Pavia, P Facheris, ...
Acta Dermato-Venereologica 101 (11), 2021
262021
Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: a single‐center retrospective comparative study
A Narcisi, M Valenti, A Cortese, F Toso, G Pavia, L Gargiulo, R Borroni, ...
Dermatologic Therapy 35 (2), e15228, 2022
252022
Non‐complicated evolution of COVID‐19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab
M Valenti, P Facheris, G Pavia, L Gargiulo, RG Borroni, A Costanzo, ...
Dermatologic Therapy 33 (4), 2020
252020
Disease severity is associated with alexithymia in patients with atopic dermatitis
A Chiricozzi, M Esposito, P Gisondi, M Valenti, N Gori, G Giovanardi, ...
Dermatology 236 (4), 329-335, 2020
252020
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: a 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)
A Narcisi, M Valenti, L Gargiulo, L Ibba, F Amoruso, G Argenziano, ...
Journal of the European Academy of Dermatology and Venereology 37 (1), 93-103, 2023
232023
A fatal case of COVID‐19 infection presenting with an erythema multiforme‐like eruption and fever
L Gargiulo, G Pavia, P Facheris, M Valenti, F Sacrini, A Narcisi, R Borroni, ...
Dermatologic Therapy 33 (4), 2020
232020
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID‐19 vaccine, successfully treated with risankizumab
G Pavia, L Gargiulo, F Spinelli, J Avagliano, M Valenti, RG Borroni, ...
Journal of the European Academy of Dermatology and Venereology 36 (7), e502, 2022
222022
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single-center real-life population
M Valenti, G Pavia, L Gargiulo, P Facheris, F Sanna, RG Borroni, ...
Journal of Dermatological Treatment 33 (3), 1638-1642, 2022
222022
Real-life effectiveness and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: a single-center 16-week study
L Gargiulo, L Ibba, A Cortese, J Avagliano, M Valenti, A Costanzo, ...
Dermatology and Therapy 13 (2), 651-660, 2023
182023
Safety of biologic therapies in patients with moderate-to-severe plaque psoriasis and concomitant viral hepatitis: a monocentric retrospective study
L Gargiulo, G Pavia, M Valenti, A Lleo de Nalda, C Perugini, A Costanzo, ...
Dermatology and Therapy 12 (5), 1263-1270, 2022
182022
Real-life efficacy of guselkumab in patients with early psoriatic arthritis
I Pantano, D Mauro, F Romano, A Gambardella, M Valenti, D Simone, ...
Rheumatology 61 (3), 1217-1221, 2022
172022
Craniopagus: the Thessaloniki–Rome experience
C Di Rocco, M Caldarelli, G Tamburrini, M Koutzoglou, L Massimi, ...
Child's Nervous System 20, 576-586, 2004
152004
Circulating tumor DNA as a marker of minimal residual disease after radical resection of colorectal liver metastases
F Marmorino, M Prisciandaro, M Giordano, E Ortolan, S Crucitta, P Manca, ...
JCO precision oncology 6, e2200244, 2022
142022
What can IBD specialists learn from IL-23 trials in dermatology?
M Valenti, A Narcisi, G Pavia, L Gargiulo, A Costanzo
Journal of Crohn's and Colitis 16 (Supplement_2), ii20-ii29, 2022
132022
Complicated coronavirus disease 2019 (COVID‐19) in a psoriatic patient treated with ixekizumab.
P Facheris, M Valenti, G Pavia, L Gargiulo, A Narcisi, A Costanzo, ...
International Journal of Dermatology 59 (8), 2020
112020
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series
L Gargiulo, L Ibba, CA Vignoli, F Piscazzi, A Cortese, G Fiorillo, F Toso, ...
Journal of Dermatological treatment 34 (1), 2023
102023
Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report
M Valenti, L Gargiulo, L Ibba, G Pavia, A Narcisi, A Costanzo
Dermatologic Therapy 35 (12), 2022
102022
The system can't perform the operation now. Try again later.
Articles 1–20